logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11717511 B1

PDFFull Text
Date of Patent:
Aug. 08, 2023

Filed:

Apr. 04, 2019

Pharmaceutical composition comprising derivative compound of 1,2-naphthoquinone for preventing or treating solid cancer or blood cancer

Applicant:

Huen Co., Ltd., Cheonan-si, KR;

Inventors:

Ki Ryang Kweon, Daejeon, KR;

Jun Young Heo, Jeonju-si, KR;

Min Ho Shong, Daejeon, KR;

Jeong Su Han, Daejeon, KR;

Min Jeong Ryu, Daejeon, KR;

Assignee:

HUEN CO., LTD., Cheonan-si, KR;

Attorney:

Rothwell, Figg, Ernst & Manbeck, P.C.

Primary Examiner:

Sun Jae Yoo

Int. Cl.
CPC ...
C07D 263/60 (2006.01); C07D 413/04 (2006.01); C07D 417/04 (2006.01); C07D 401/04 (2006.01); C07D 405/04 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01); A61K 31/4184 (2006.01); A61K 31/4192 (2006.01); A61K 31/423 (2006.01); A61K 31/428 (2006.01); A61K 31/4745 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4184 (2013.01); A61K 31/4192 (2013.01); A61K 31/423 (2013.01); A61K 31/428 (2013.01); A61K 31/4745 (2013.01); A61P 35/00 (2018.01); A61P 35/02 (2018.01); C07D 263/60 (2013.01); C07D 401/04 (2013.01); C07D 405/04 (2013.01); C07D 413/04 (2013.01); C07D 417/04 (2013.01);
Abstract

The present invention relates to a pharmaceutical composition for preventing or treating solid cancer and blood cancers such as acute leukemia and chronic leukemia, comprising a derivative compound of 1,2-naphthoquinone or a pharmaceutically acceptable salt thereof as an effective component. The derivative compound of 1,2-naphthoquinone is highly effective in killing cancer cells of various solid cancers, acute leukemia, and chronic leukemia, and thus can be beneficially used as a pharmaceutical composition for preventing or treating cancers, especially solid cancers, acute leukemia, and chronic leukemia.

Find Patent Forward Citations

Kweon, Ki. (2023). Pharmaceutical composition comprising derivative compound of 1,2-naphthoquinone for preventing or treating solid cancer or blood cancer (U.S. Patent No. 11717511). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11717511

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…